• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生理氧张力条件下脐血造血干/祖细胞的体外扩增:对细胞增殖、分化和代谢的明确影响

Ex vivo expansion of cord blood haematopoietic stem/progenitor cells under physiological oxygen tensions: clear-cut effects on cell proliferation, differentiation and metabolism.

作者信息

Andrade Pedro Z, de Soure António M, Dos Santos Francisco, Paiva Artur, Cabral Joaquim M S, da Silva Cláudia L

机构信息

Department of Bioengineering and Institute for Biotechnology and Bioengineering (IBB), Instituto Superior Técnico, Technical University of Lisbon, Portugal.

Histocompatibility Centre of Coimbra, Portugal.

出版信息

J Tissue Eng Regen Med. 2015 Oct;9(10):1172-81. doi: 10.1002/term.1731. Epub 2013 Apr 17.

DOI:10.1002/term.1731
PMID:23596131
Abstract

Physiologically low O(2) tensions are believed to regulate haematopoietic stem cell (HSC) functions in the bone marrow (BM; 0-5%). In turn, placenta and umbilical cord are characterized by slightly higher physiological O(2) tensions (3-10%). We hypothesized that O(2) concentrations within this range may be exploited to augment the ex vivo expansion/maintenance of HSCs from umbilical cord (placental) blood (UCB). The expansion of UCB CD34(+) -enriched cells was studied in co-culture with BM mesenchymal stem/stromal cells (MSCs) under 2%, 5%, 10% and 21% O(2). 2% O(2) resulted in a significantly lower CD34(+) cell expansion (25-fold vs 60-, 64- and 92-fold at day 10 for 5%, 21%, 10% O(2), respectively). In turn, 10% O(2) promoted the highest CD34(+) CD90(+) cell expansion, reaching 22 ± 5.4- vs 5.6 ± 2.4- and 5.7 ± 2.0-fold for 2%, 5% and 21% O(2), respectively, after 14 days. Similar differentiation patterns were observed under different O(2) tensions, being primarily shifted towards the neutrophil lineage. Cell division kinetics revealed a higher proliferative status of cells cultured under 10% and 21% vs 2% O(2). Expectedly, higher specific glucose consumption and lactate production rates were determined at 2% O(2) when compared to higher O(2) concentrations (5-21%). Overall, these results suggest that physiological oxygen tensions, in particular 10% O(2), can maximize the ex vivo expansion of UCB stem/progenitor cells in co-culture with BM MSCs. Importantly, these studies highlight the importance of exploiting knowledge of the intricate microenvironment of the haematopoietic niche towards the definition of efficient and controlled ex vivo culture systems capable of generating large HSCs numbers for clinical applications.

摘要

生理低氧张力被认为可调节骨髓中造血干细胞(HSC)的功能(骨髓中氧张力为0 - 5%)。相反,胎盘和脐带的生理氧张力略高(3 - 10%)。我们推测,这个范围内的氧浓度可用于增强脐带(胎盘)血(UCB)中HSC的体外扩增/维持。在2%、5%、10%和21%氧浓度下,研究了UCB中富集的CD34⁺细胞与骨髓间充质干/基质细胞(MSC)共培养时的扩增情况。2%氧浓度导致CD34⁺细胞扩增显著降低(第10天时,2%氧浓度下扩增25倍,而5%、21%、10%氧浓度下分别为60倍、64倍和92倍)。相反,14天后,10%氧浓度促进了最高的CD34⁺CD90⁺细胞扩增,2%、5%和21%氧浓度下分别达到22±5.4倍、5.6±2.4倍和5.7±2.0倍。在不同氧张力下观察到类似的分化模式,主要向中性粒细胞谱系转变。细胞分裂动力学显示,与2%氧浓度相比,10%和21%氧浓度下培养的细胞增殖状态更高。与较高氧浓度(5 - 21%)相比,2%氧浓度下特定葡萄糖消耗率和乳酸产生率更高是预期的。总体而言,这些结果表明,生理氧张力,特别是10%氧浓度,可在与骨髓MSC共培养时使UCB干/祖细胞的体外扩增最大化。重要的是,这些研究突出了利用造血微环境复杂知识来定义高效且可控的体外培养系统的重要性,该系统能够产生大量用于临床应用的HSC。

相似文献

1
Ex vivo expansion of cord blood haematopoietic stem/progenitor cells under physiological oxygen tensions: clear-cut effects on cell proliferation, differentiation and metabolism.生理氧张力条件下脐血造血干/祖细胞的体外扩增:对细胞增殖、分化和代谢的明确影响
J Tissue Eng Regen Med. 2015 Oct;9(10):1172-81. doi: 10.1002/term.1731. Epub 2013 Apr 17.
2
Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.脐血造血祖细胞与细胞生态位之间的动态细胞间相互作用对于 CD34+、CD34+CD38-和早期淋巴样 CD7+细胞的扩增是必不可少的。
J Tissue Eng Regen Med. 2010 Feb;4(2):149-58. doi: 10.1002/term.226.
3
Initial CD34+ cell-enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion.脐血初始 CD34+ 细胞的富集决定了体外扩增后造血干/祖细胞的产量。
J Cell Biochem. 2011 Jul;112(7):1822-31. doi: 10.1002/jcb.23099.
4
Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.从胎盘和脐带分离的间充质干细胞作为饲养层支持脐血来源的CD34(+)细胞体外扩增的差异能力。
Stem Cell Res Ther. 2015 Oct 19;6:201. doi: 10.1186/s13287-015-0194-y.
5
Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells.在培养脐血 CD34+细胞时,低氧浓度与间充质基质细胞联合作用可提高造血干细胞的维持和增殖能力。
J Cell Physiol. 2012 Jun;227(6):2750-8. doi: 10.1002/jcp.23019.
6
Evaluation of umbilical cord blood CD34 (+) hematopoietic stem cell expansion in co-culture with bone marrow mesenchymal stem cells in the presence of TEPA.在TEPA存在的情况下,评估脐带血CD34(+)造血干细胞与骨髓间充质干细胞共培养时的扩增情况。
Hematology. 2013 Jan;18(1):39-45. doi: 10.1179/1607845412Y.0000000034. Epub 2012 Nov 19.
7
Low oxygen tension favored expansion and hematopoietic reconstitution of CD34(+) CD38(-) cells expanded from human cord blood-derived CD34(+) Cells.低氧张力有利于从人脐带血来源的CD34(+)细胞扩增而来的CD34(+) CD38(-)细胞的扩增和造血重建。
Biotechnol J. 2016 Jul;11(7):945-53. doi: 10.1002/biot.201500497. Epub 2016 Apr 29.
8
Evaluation of umbilical cord blood CD34+ hematopoietic stem cells expansion with inhibition of TGF-β receptorII in co-culture with bone marrow mesenchymal stromal cells.在与骨髓间充质基质细胞共培养中,通过抑制转化生长因子-β受体II评估脐带血CD34+造血干细胞的扩增情况。
Tissue Cell. 2016 Aug;48(4):305-11. doi: 10.1016/j.tice.2016.06.003. Epub 2016 Jun 8.
9
Ex vivo expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS-5 stromal cell line.从人脐带血中的造血干/祖细胞在 MS-5 基质细胞系制备的脱细胞支架上的体外扩增。
J Tissue Eng Regen Med. 2013 Nov;7(11):871-83. doi: 10.1002/term.1479. Epub 2012 Apr 17.
10
Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells.系统描绘与间充质干细胞共培养时用于扩增造血干细胞/祖细胞的最佳细胞因子浓度。
Mol Biosyst. 2010 Jul;6(7):1207-15. doi: 10.1039/b922637k. Epub 2010 Apr 27.

引用本文的文献

1
Hypothermic Preservation of Adipose-Derived Mesenchymal Stromal Cells as a Viable Solution for the Storage and Distribution of Cell Therapy Products.低温保存脂肪来源的间充质基质细胞作为细胞治疗产品储存和分发的可行解决方案。
Bioengineering (Basel). 2022 Dec 14;9(12):805. doi: 10.3390/bioengineering9120805.
2
Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34-enriched cells.脐血源 CD34 阳性细胞中间充质基质细胞来源对其造血支持能力的影响。
Stem Cell Res Ther. 2021 Jul 13;12(1):399. doi: 10.1186/s13287-021-02474-8.
3
Tailored Cytokine Optimization for Culture Platforms Targeting the Expansion of Human Hematopoietic Stem/Progenitor Cells.
针对人类造血干/祖细胞扩增的培养平台的定制细胞因子优化
Front Bioeng Biotechnol. 2020 Sep 25;8:573282. doi: 10.3389/fbioe.2020.573282. eCollection 2020.
4
Establishment of an in vitro placental barrier model cultured under physiologically relevant oxygen levels.建立在生理相关氧水平下培养的体外胎盘屏障模型。
Mol Hum Reprod. 2020 May 15;26(5):353-365. doi: 10.1093/molehr/gaaa018.
5
Modelling mesenchymal stromal cell growth in a packed bed bioreactor with a gas permeable wall.在具有透气壁的填充床生物反应器中模拟间充质基质细胞的生长。
PLoS One. 2018 Aug 27;13(8):e0202079. doi: 10.1371/journal.pone.0202079. eCollection 2018.
6
Proliferation extent of CD34 cells as a key parameter to maximize megakaryocytic differentiation of umbilical cord blood-derived hematopoietic stem/progenitor cells in a two-stage culture protocol.在两阶段培养方案中,CD34细胞的增殖程度作为一个关键参数,可使脐带血来源的造血干细胞/祖细胞的巨核细胞分化最大化。
Biotechnol Rep (Amst). 2014 Jul 16;4:50-55. doi: 10.1016/j.btre.2014.07.002. eCollection 2014 Dec.
7
Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood.脐血造血干细胞和祖细胞的体外扩增
Acta Naturae. 2016 Jul-Sep;8(3):6-16.
8
Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.探索骨髓微环境:转化医学见解与癌症驱动的功能障碍
Nat Rev Rheumatol. 2016 Mar;12(3):154-68. doi: 10.1038/nrrheum.2015.160. Epub 2015 Nov 26.